Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center

Pot Compound Alters Levels of Seizure Drug in Epilepsy Patients

FRIDAY, Aug. 11, 2017 -- Scientists experimenting with the marijuana compound cannabidiol as an epilepsy treatment must evaluate any interactions with other anti-seizure drugs patients are taking, researchers report. The new research from the Universit

Heart Risk Up if Hospitalized for Pneumonia or Sepsis

FRIDAY, Aug. 11, 2017 -- Adults whove been hospitalized with pneumonia or sepsis have a higher risk of heart disease, a new European study reports. Researchers examined data from nearly 237,000 Swedish men. They were followed from age 18 into middle ag

FDA Approves Vyxeos

FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia

FDA Approves Mavyret

August 3, 2017 -- The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients w

Too Soon to Widely Recommend Ketamine for Depression

FRIDAY, July 28, 2017 -- The drug ketamine -- known as Special K on the party scene -- shows promise as a depression treatment. But researchers arent ready to recommend it because its long-term effects remain unknown. That gap in knowledge must be fill

FDA Looks to Reduce Nicotine in Cigarettes

FRIDAY, July 28, 2017 -- The U.S. Food and Drug Administration will focus on reducing nicotine levels in cigarettes to make them less addictive, while also making other nicotine products -- including patches and gum -- safer, agency officials said Friday.